Pesquisar
Quoin Pharmaceuticals Ltd
QNRXAdicionar à lista de desejos
6.900USD
-0.070-1.00%
Fechamento 09-10 16:00（ET）
486.44MValor de mercado
PerdaP/L TTM
Após o expediente (ET)0.000USD0.000
Após o expediente (ET)Mais detalhes de Quoin Pharmaceuticals Ltd Empresa
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.
Quoin Pharmaceuticals Ltd Perfil
Código da empresaQNRX
Nome da EmpresaQuoin Pharmaceuticals Ltd
Data de listagemNov 01, 1989
CEOMyers (Michael)
Número de funcionários3
Tipo de títulosDepository Receipt
Fim do ano fiscalNov 01
Endereço23 Hata'as Street
CidadeKFAR SABA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal44425
Telefone97299741444
Sitehttps://quoinpharma.com/
Código da empresaQNRX
Data de listagemNov 01, 1989
CEOMyers (Michael)
Executivos da empresa Quoin Pharmaceuticals Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael Myers, Ph.D.
Dr. Michael Myers, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
37.71K
+54.33%
Ms. Sally Lawlor
Ms. Sally Lawlor
Chief Financial Officer
Chief Financial Officer
10.68K
+95.88%
Dr. Amotz Nehushtan
Dr. Amotz Nehushtan
Vice President - Research & Development & Product Development
Vice President - Research & Development & Product Development
--
--
Mr. Guy Sapir
Mr. Guy Sapir
Internal Auditor
Internal Auditor
--
--
Dr. Amos Ofer
Dr. Amos Ofer
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Mr. David L. Braun
Mr. David L. Braun
Independent Director
Independent Director
--
--
Mr. Jonathan Burgin, CPA
Mr. Jonathan Burgin, CPA
Independent External Director
Independent External Director
--
--
Ms. Ronit Biran
Ms. Ronit Biran
Independent Director
Independent Director
--
--
Mr. Yali Sheffi
Mr. Yali Sheffi
Independent External Director
Independent External Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael Myers, Ph.D.
Dr. Michael Myers, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
37.71K
+54.33%
Ms. Sally Lawlor
Ms. Sally Lawlor
Chief Financial Officer
Chief Financial Officer
10.68K
+95.88%
Dr. Amotz Nehushtan
Dr. Amotz Nehushtan
Vice President - Research & Development & Product Development
Vice President - Research & Development & Product Development
--
--
Mr. Guy Sapir
Mr. Guy Sapir
Internal Auditor
Internal Auditor
--
--
Dr. Amos Ofer
Dr. Amos Ofer
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Mr. David L. Braun
Mr. David L. Braun
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Quoin Pharmaceuticals Ltd?
Os cinco principais acionistas de Quoin Pharmaceuticals Ltd são: Dr. Michael Myers, Ph.D.
Quantas instituições possuem ações da Quoin Pharmaceuticals Ltd (QNRX)?
Em 2026Q1, 40 instituições possuíam ações da Quoin Pharmaceuticals Ltd, com valor de mercado aproximado de 874.98K, representando 43.66% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 369388.00.